Literature DB >> 29453249

Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice.

Jacob T Jackson1, Ashley P Ng2,3, Benjamin J Shields1, Sue Haupt4, Ygal Haupt4, Matthew P McCormack1.   

Abstract

The hematopoietically expressed homeobox (Hhex) transcription factor is overexpressed in human myeloid leukemias. Conditional knockout models of murine acute myeloid leukemia indicate that Hhex maintains leukemia stem cell self-renewal by enabling Polycomb-mediated epigenetic repression of the Cdkn2a tumor suppressor locus, encoding p16Ink4a and p19Arf However, whether Hhex overexpression also affects hematopoietic differentiation is unknown. To study this, we retrovirally overexpressed Hhex in hematopoietic progenitors. This enabled serial replating of myeloid progenitors, leading to the rapid establishment of interleukin-3 (IL-3)-dependent promyelocytic cell lines. Use of a Hhex-ERT2 fusion protein demonstrated that continuous nuclear Hhex is required for transformation, and structure function analysis demonstrated a requirement of the DNA-binding and N-terminal-repressive domains of Hhex for promyelocytic transformation. This included the N-terminal promyelocytic leukemia protein (Pml) interaction domain, although deletion of Pml failed to prevent Hhex-induced promyelocyte transformation, implying other critical partners. Furthermore, deletion of p16Ink4a or p19Arf did not promote promyelocyte transformation, indicating that repression of distinct Hhex target genes is required for this process. Indeed, transcriptome analysis showed that Hhex overexpression resulted in repression of several myeloid developmental genes. To test the potential for Hhex overexpression to contribute to leukemic transformation, Hhex-transformed promyelocyte lines were rendered growth factor-independent using a constitutively active IL-3 receptor common β subunit (βcV449E). The resultant cell lines resulted in a rapid promyelocytic leukemia in vivo. Thus, Hhex overexpression can contribute to myeloid leukemia via multiple mechanisms including differentiation blockade and enabling epigenetic repression of the Cdkn2a locus.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29453249      PMCID: PMC5858476          DOI: 10.1182/bloodadvances.2017013243

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  43 in total

1.  Novel murine myeloid cell lines that exhibit a differentiation switch in response to IL-3 or GM-CSF, or to different constitutively active mutants of the GM-CSF receptor beta subunit.

Authors:  M P McCormack; T J Gonda
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

2.  Homeobox gene Hex is essential for onset of mouse embryonic liver development and differentiation of the monocyte lineage.

Authors:  V W Keng; H Yagi; M Ikawa; T Nagano; Z Myint; K Yamada; T Tanaka; A Sato; I Muramatsu; M Okabe; M Sato; T Noguchi
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

3.  Role of PML in cell growth and the retinoic acid pathway.

Authors:  Z G Wang; L Delva; M Gaboli; R Rivi; M Giorgio; C Cordon-Cardo; F Grosveld; P P Pandolfi
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

4.  PCR cloning of an orphan homeobox gene (PRH) preferentially expressed in myeloid and liver cells.

Authors:  R Hromas; J Radich; S Collins
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

5.  Hhex is Required at Multiple Stages of Adult Hematopoietic Stem and Progenitor Cell Differentiation.

Authors:  Charnise Goodings; Elizabeth Smith; Elizabeth Mathias; Natalina Elliott; Susan M Cleveland; Rati M Tripathi; Justin H Layer; Xi Chen; Yan Guo; Yu Shyr; Rizwan Hamid; Yang Du; Utpal P Davé
Journal:  Stem Cells       Date:  2015-05-27       Impact factor: 6.277

6.  Ligand-activated site-specific recombination in mice.

Authors:  R Feil; J Brocard; B Mascrez; M LeMeur; D Metzger; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 7.  Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion.

Authors:  Kevin Gaston; Maria-Angela Tsitsilianos; Kerry Wadey; Padma-Sheela Jayaraman
Journal:  Cell Biosci       Date:  2016-02-13       Impact factor: 7.133

8.  RUNX1 cooperates with FLT3-ITD to induce leukemia.

Authors:  Kira Behrens; Katrin Maul; Nilgün Tekin; Neele Kriebitzsch; Daniela Indenbirken; Vladimir Prassolov; Ursula Müller; Hubert Serve; Jörg Cammenga; Carol Stocking
Journal:  J Exp Med       Date:  2017-02-17       Impact factor: 14.307

9.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

10.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Nucleic Acids Res       Date:  2013-04-04       Impact factor: 16.971

View more
  4 in total

1.  Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.

Authors:  Sonja I Berndt; Joseph Vijai; Yolanda Benavente; Nicola J Camp; Alexandra Nieters; Zhaoming Wang; Karin E Smedby; Geffen Kleinstern; Henrik Hjalgrim; Caroline Besson; Christine F Skibola; Lindsay M Morton; Angela R Brooks-Wilson; Lauren R Teras; Charles Breeze; Joshua Arias; Hans-Olov Adami; Demetrius Albanes; Kenneth C Anderson; Stephen M Ansell; Bryan Bassig; Nikolaus Becker; Parveen Bhatti; Brenda M Birmann; Paolo Boffetta; Paige M Bracci; Paul Brennan; Elizabeth E Brown; Laurie Burdett; Lisa A Cannon-Albright; Ellen T Chang; Brian C H Chiu; Charles C Chung; Jacqueline Clavel; Pierluigi Cocco; Graham Colditz; Lucia Conde; David V Conti; David G Cox; Karen Curtin; Delphine Casabonne; Immaculata De Vivo; W Ryan Diver; Ahmet Dogan; Christopher K Edlund; Lenka Foretova; Joseph F Fraumeni; Attilio Gabbas; Hervé Ghesquières; Graham G Giles; Sally Glaser; Martha Glenn; Bengt Glimelius; Jian Gu; Thomas M Habermann; Christopher A Haiman; Corinne Haioun; Jonathan N Hofmann; Theodore R Holford; Elizabeth A Holly; Amy Hutchinson; Aalin Izhar; Rebecca D Jackson; Ruth F Jarrett; Rudolph Kaaks; Eleanor Kane; Laurence N Kolonel; Yinfei Kong; Peter Kraft; Anne Kricker; Annette Lake; Qing Lan; Charles Lawrence; Dalin Li; Mark Liebow; Brian K Link; Corrado Magnani; Marc Maynadie; James McKay; Mads Melbye; Lucia Miligi; Roger L Milne; Thierry J Molina; Alain Monnereau; Rebecca Montalvan; Kari E North; Anne J Novak; Kenan Onel; Mark P Purdue; Kristin A Rand; Elio Riboli; Jacques Riby; Eve Roman; Gilles Salles; Douglas W Sborov; Richard K Severson; Tait D Shanafelt; Martyn T Smith; Alexandra Smith; Kevin W Song; Lei Song; Melissa C Southey; John J Spinelli; Anthony Staines; Deborah Stephens; Heather J Sutherland; Kaitlyn Tkachuk; Carrie A Thompson; Hervé Tilly; Lesley F Tinker; Ruth C Travis; Jenny Turner; Celine M Vachon; Claire M Vajdic; Anke Van Den Berg; David J Van Den Berg; Roel C H Vermeulen; Paolo Vineis; Sophia S Wang; Elisabete Weiderpass; George J Weiner; Stephanie Weinstein; Nicole Wong Doo; Yuanqing Ye; Meredith Yeager; Kai Yu; Anne Zeleniuch-Jacquotte; Yawei Zhang; Tongzhang Zheng; Elad Ziv; Joshua Sampson; Nilanjan Chatterjee; Kenneth Offit; Wendy Cozen; Xifeng Wu; James R Cerhan; Stephen J Chanock; Susan L Slager; Nathaniel Rothman
Journal:  Leukemia       Date:  2022-10-22       Impact factor: 12.883

2.  Systems-level identification of key transcription factors in immune cell specification.

Authors:  Cong Liu; Kyla Omilusik; Clara Toma; Nadia S Kurd; John T Chang; Ananda W Goldrath; Wei Wang
Journal:  PLoS Comput Biol       Date:  2022-09-26       Impact factor: 4.779

3.  HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development.

Authors:  Sébastien Gauvrit; Alethia Villasenor; Boris Strilic; Philip Kitchen; Michelle M Collins; Rubén Marín-Juez; Stefan Guenther; Hans-Martin Maischein; Nana Fukuda; Maurice A Canham; Joshua M Brickman; Clifford W Bogue; Padma-Sheela Jayaraman; Didier Y R Stainier
Journal:  Nat Commun       Date:  2018-07-13       Impact factor: 14.919

4.  NKL homeobox gene activities in normal and malignant myeloid cells.

Authors:  Stefan Nagel; Michaela Scherr; Roderick A F MacLeod; Claudia Pommerenke; Max Koeppel; Corinna Meyer; Maren Kaufmann; Iris Dallmann; Hans G Drexler
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.